✦ LIBER ✦

A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes

✍ Scribed by Gidwani, Risha; Khan, Zeba M.; Fenaux, Pierre; Beach, C. L.; Pashos, Chris L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN65 Cost-Effectiveness Analysis of Hyp

✍ Cantor, E.; Izquierdo, C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The use of low-dose protracted oral clof

✍ Al Ustwani, Omar; Greene, Jessica D.; Wetzler, Meir 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 168 KB

Retrospective Analysis of Prognostic Fac

✍ Jabbour, Elias; Kantarjian, Hagop; O'Brien, Susan; Kadia, Tapan; Malik, Asifa; W 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 255 KB

PIN31 COST-EFFECTIVENESS ANALYSIS OF TEL

✍ Chen, W; Hou, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Cost-effectiveness analysis of linezolid

✍ M. Bounthavong; D. I. Hsu; M. P. Okamoto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

PGS5 A COST-EFFECTIVENESS ANALYSIS OF ES

✍ A Karokis; A Christodoulopoulou; P Wahlqvist 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB